NasdaqGM - Nasdaq Real Time Price
USD
ADMA Biologics, Inc. (ADMA)
13.21
+2.73
(+26.05%)
At close: November 5 at 4:00:01 PM EST
13.11
-0.10
(-0.76%)
Pre-Market: 8:10:05 AM EST
Trade ADMA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Mizuho
79/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
11/5/2026
Analyst
Cantor Fitzgerald
Rating Action
Maintains
Rating
Neutral
Price Action
Raises
Price Target
12 -> 13
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Mizuho
|
79 | 74 | 98 | Outperform
|
17 | 2026-07-15 |
|
Cantor Fitzgerald
|
75 | 70 | 85 | Neutral
|
13 | 2026-11-06 |
Rows per page
1-2 of 2
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 11/5/2026 |
| Maintains | Mizuho: Outperform to Outperform | 7/15/2026 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/7/2026 |
| Maintains | Mizuho: Outperform to Outperform | 5/7/2026 |
| Initiated | Canaccord Genuity: Buy | 4/21/2026 |
| Maintains | Mizuho: Outperform to Outperform | 4/13/2026 |
